Patent application number | Description | Published |
20100214184 | ANTENNA DEVICES AND SYSTEMS FOR MULTI-BAND COVERAGE IN A COMPACT VOLUME - A multi-band antenna device includes a primary antenna with a helical component and a folded component. A wire is formed in a helix to construct the helical component and a wire is formed in a folded-over fashion to form the folded component. The folded component is disposed inside the helix. The helical component and folded component may be formed with separate wires or as one continuous wire. The primary antenna is for resonating in multiple frequency bands including a first frequency band correlated with the helical component and a second frequency band correlated with the folded component. A secondary antenna may be included to provide diversity and possibly other frequency bands. The secondary antenna includes a planar inverted F antenna. | 08-26-2010 |
20110043408 | COMPACT MULTI-BAND PLANAR INVERTED F ANTENNA - A simple, compact multi-band PIFA including two arm portions, where one arm portion is grounded at two points to form a loop, a ground plane, and a plastic carrier and housing. The antenna radiates a same signal from both arm portions, at different efficiencies according to the radiated frequency and the effective length of each arm. The antenna is made from a single standard metal sheet by cutting it and is assembled with the metal ground plane and the other plastic parts. In one embodiment, the antenna is folded into a 3D U-shape to reduce its size for use in mobile communication devices. In another embodiment, the antenna is a penta-band antenna with return loss of −6 B or better and measures 40×8×8 mm or smaller. | 02-24-2011 |
20120076184 | MULTIBAND ANTENNA FOR A MOBILE DEVICE - A multiband antenna for a mobile device is disclosed. The mobile device includes a multiband antenna configured to communicate with a base station. The multiband antenna includes a ground plane, a ground plane extension, and a plurality of antenna arms. The ground plane, the ground plane extension, and the plurality of antenna arms are configured to communicate signals in multiple frequency bands, where the ground plane and the ground plane extension have a length proportional to approximately a quarter wavelength of a frequency in the multiple frequency bands. The mobile device further includes a modulator and demodulator configured to modulate signal for transmission and demodulate signal received from the base station, and a controller configured to control communication of signals using the multiband antenna and the modem. | 03-29-2012 |
20140071004 | BATTERY ANTENNA HAVING A SECONDARY RADIATOR - A combination battery and antenna includes a battery having a positive contact and a negative contact, at least one of the positive contact and the negative contact comprising an antenna coupled to a matching circuit and to a radio frequency choke, whereby direct current (DC) is supplied to a battery circuit and a radio frequency (RF) signal is supplied to an RF circuit, and at least one secondary radiator parasitically coupled to the at least one of the positive contact and the negative contact of the battery. | 03-13-2014 |
20140266920 | MULTIPURPOSE ANTENNA - A multiband antenna for a wireless device includes a housing base portion, housing antenna portion and a feed contact. The housing base portion configured to receive radio circuitry thereon and include a first peripheral edge and a first conductive material. The housing antenna portion spaced away from and substantially opposed to the housing base portion, including a second peripheral edge and a second conductive material. The housing base and antenna portions together forming an outermost housing of the mobile wireless device, enclosing the radio circuitry there between. The first and second peripheral edges forming opposed lengthwise edges of a slot having a width formed by a distance between the first and second peripheral edges. The feed contact coupling the housing base portion, the housing antenna portion and the radio circuitry for providing at least one driving frequency to at least the housing antenna portion from the radio circuitry. | 09-18-2014 |
20140269217 | USER CONTROL INTERFACE BUTTON FLEX ANTENNA SYSTEM - A compact antenna system that provides an antenna capable of transmitting and/or receiving radio signals configured on a flexible substrate material supporting user control interface buttons. In an embodiment, an antenna may be formed on a user control interface button flex between the wire traces used to couple the user control interface buttons to a printed circuit board. In order to prevent the interference on the antenna that may be caused when current passes through the wire traces coupling the user control interface buttons to the printed circuit board, an RF choke (i.e., LC filter) circuit and bypass capacitors may be configured along each wire trace. In another embodiment, the wire trace coupling a user control interface button to the printed circuit board may be configured to serve the dual purposes of coupling the user control interface button to the printed circuit board; and functioning as an antenna capable of transmitting and/or receiving wireless radio signals. | 09-18-2014 |
Patent application number | Description | Published |
20090284218 | METHOD AND APPARATUS FOR AN ENLARGED WIRELESS CHARGING AREA - Exemplary embodiments are directed to wireless power transfer including a plurality of antenna circuits spatially arranged and each including an antenna configured to resonate and generate a near field coupling mode region thereabout in response to a driving signal from a power amplifier. The apparatus further includes a processor configured to control activation of resonance of each of the plurality of antenna circuits. The method for wirelessly charging includes driving a signal from a power amplifier and controlling activation of resonance of a plurality of antenna circuits spatially arranged and each including an antenna configured to resonate in response to the driving signal. | 11-19-2009 |
20090284227 | RECEIVE ANTENNA FOR WIRELESS POWER TRANSFER - Exemplary embodiments are directed to wireless power transfer to an electronic circuit including a wireless charging receive antenna comprising a first loop of an energy receiving conductor and at least another loop of said energy receiving conductor electrically coupled to the first loop. The loops form a multi-turn loop antenna to resonate at a wireless charging frequency and provide wirelessly received power to the electronic device. The multi-turn loop antenna is configured for affixing to a housing of the wireless device. | 11-19-2009 |
20100231461 | FREQUENCY SELECTIVE MULTI-BAND ANTENNA FOR WIRELESS COMMUNICATION DEVICES - A multi-band antenna with improved antenna efficiency across a broad range of operative frequency bands with reduced physical size is described. The multi-band antenna includes a modified monopole element coupled to multiple antenna loading elements variably selectable to tune to one of a plurality of resonant frequencies. In one exemplary embodiment, the modified monopole element has a geometry other than that of a traditional monopole element and includes a switch array disposed between the modified monopole element and the multiple antenna loading elements and configured to couple a selected one or more of the antenna loading elements to the modified monopole element when tuning to a desired one of the plurality of resonant frequencies. The multi-band antenna resonant frequency is controlled by a wireless communication device selecting among the multiple antenna loading elements for tuning the multi-band antenna between operative frequency bands. | 09-16-2010 |
20100231462 | MULTI-BAND SERIALLY CONNECTED ANTENNA ELEMENT FOR MULTI-BAND WIRELESS COMMUNICATION DEVICES - A multi-band antenna including a high-band antenna and a low-band antenna coupled in serial cascade fashion, where the low-band antenna is coupled at a position relative to the high-band antenna characterized by low coupling between the low-band antenna and the high-band antenna in corresponding operating frequency bands. In one exemplary embodiment, the high-band antenna is a high-band modified monopole antenna. In another, the high-band modified monopole antenna is a high-band quarter ellipse monopole antenna element and the low-band antenna is a low-band modified monopole antenna. | 09-16-2010 |
20100231472 | ORTHOGONAL TUNABLE ANTENNA ARRAY FOR WIRELESS COMMUNICATION DEVICES - A multi-band antenna array for use in wireless communication devices with up to three simultaneous operating modes with improved antenna efficiency and reduced antenna coupling across a broad range of operative frequency bands with reduced physical size is described. The multi-band antenna array includes at least two loop antenna elements, each of which is orthogonal to, and arranged in an embedded manner, relative to each other. Each loop antenna in the multi-band antenna array may include a corresponding tuning element for tuning to a desired resonant frequency, and be comprised of an upper and lower half with the corresponding tuning element coupled therebetween. | 09-16-2010 |
20100245205 | WIDEBAND ANTENNA FOR PORTABLE COMPUTERS - A wideband antenna, for use in portable computers incorporating at least one wireless communication device, with improved radiated antenna efficiency across a broad range of operating frequency bands with minimal additional physical size or cost, is described. In an exemplary embodiment, the wideband antenna is defined by at least a first and second housing, where a first metal structure in at least a first one of the at least a first and second housings is commonly connected to at least two antenna RF feed ports at a boundary of the at least a first and second housing. In a further exemplary embodiment, the device is a portable computer, and the first housing is an upper display housing, the second housing includes a wireless communication device with at least two RF signal paths to at least two antenna RF feed ports, and the second housing further includes a second metal structure commonly connected to at least two antenna RF feed ports of the wideband antenna. | 09-30-2010 |
20120075151 | MULTI-BAND ANTENNA DEVICE - Exemplary embodiments are directed to an antenna device. A device may include an antenna element including a first electrically conductive element oriented in a first direction and a second electrically conductive element oriented in a second, different direction, the first and second conductive elements being electrically connected at one respective end. The device may further include a matching circuit operably coupled to the antenna element. | 03-29-2012 |
20120230377 | Multiband Antenna for a Mobile Device - A multiband antenna for a mobile device is disclosed. The multiband antenna includes a plurality of flexible antenna arms configured to communicate signals in multiple frequency bands, a flexible antenna counterpoise, a battery configured to provide power to the multiband antenna, and control logic configured to control communication of signals of the multiband antenna, where the plurality of flexible antenna arms, the flexible antenna counterpoise, the battery, and the control logic are bonded to a flexible insulation material. The multiband antenna further includes at least a portion of circuit schematics that connect the plurality of flexible antenna arms, the flexible antenna counterpoise, the battery and the control logic are placed and routed on the flexible insulation material. | 09-13-2012 |
20130002403 | RFID SYSTEM WITH IMPROVED COVERAGE AND INCREASED READING DISTANCE - A radio frequency identification (RFID) system with a parasitic element to improve coverage and increase reading distance of RFID tags is disclosed. The parasitic element may be a loop of a conductive material and is not physically connected to any circuit. One or more RFID tags may be located within a predetermined distance of the parasitic element. The parasitic element receives a first signal from an RFID reader and re-radiates the first signal. The re-radiation improves the coverage of the RFID system. An RFID tag receives the re-radiated first signal from the parasitic element and, in response, transmits a second signal. The parasitic element receives the second signal from the RFID tag and re-radiates the second signal. The RFID reader receives the re-radiated second signal from the parasitic element and reads the information sent in the second signal by the RFID tag. | 01-03-2013 |
20130016024 | WIDEBAND ANTENNA SYSTEM WITH MULTIPLE ANTENNAS AND AT LEAST ONE PARASITIC ELEMENTAANM Shi; GuiningAACI San DiegoAAST CAAACO USAAGP Shi; Guining San Diego CA USAANM Tran; Allen Minh-TrietAACI San DiegoAAST CAAACO USAAGP Tran; Allen Minh-Triet San Diego CA USAANM Wyrwich; Elizabeth M.AACI San DiegoAAST CAAACO USAAGP Wyrwich; Elizabeth M. San Diego CA US - A wideband antenna system with multiple antennas and at least one parasitic element is disclosed. In an exemplary design, an apparatus includes a first antenna, a second antenna, and a parasitic element. The first antenna has a shape of an open-ended loop with two ends that overlap and are separated by a gap. The second antenna may also have a shape of an open-ended loop with two ends that overlap and are separated by a gap. The parasitic element is located between the first and second antennas. The first and second antennas may be placed side by side on a board, located at either the top end or the bottom end of a wireless device, and/or formed on opposite sides (e.g., the front and back sides) of the board. The parasitic element may be formed on a plane that is perpendicular to the plane on which the first and second antennas are formed. | 01-17-2013 |
20130021204 | APPARATUS AND METHOD FOR WIRELESS NETWORK ENHANCEMENT VIA VARIABLE DOWN TILT - Apparatus and methods for controlling antenna down tilt in a mixed coordinated/non-coordinated network include receiving one or more input signals defining a waveform to be transmitted, for determining a tilt angle state to be applied to the antenna based on the one or more input signals, and for transmitting a tilt control signal if the determined tilt angle state differs from a current tilt angle state associated with the antenna. | 01-24-2013 |
20130214989 | MULTI-PLANAR ANTENNA INSERT - Techniques for designing a sensor module that may be inserted into a container, for example, a box, for tracking RFID-labeled items enclosed in the container. In an exemplary embodiment, at least two planar surfaces are adjoined along a linear interface. Each of the planar surfaces supports a planar antenna whose radiation pattern may cover the volume of the container. A battery-powered tracking unit is attached to at least one of the planar surfaces to drive the planar antennas. In an exemplary embodiment, the planar antennas may be driven in succession to avoid collisions between the RFID communication signals, and for better RFID coverage of the items enclosed in the container. | 08-22-2013 |
20140327577 | LOW COST HIGH PERFORMANCE AIRCRAFT ANTENNA FOR ADVANCED GROUND TO AIR INTERNET SYSTEM - A high gain multi-beam aircraft blade antenna of an air-to-ground antenna systems includes multiple columnar matrix antenna elements housed within a blade. The elements are arranged to create independently steerable directed beams. A first independently steerable beam is used to provide communication. A second independently steerable beam is used to simultaneously search other signals. | 11-06-2014 |
20140327588 | ANTENNA STRUCTURE HAVING ORTHOGONAL POLARIZATIONS - An antenna structure is disclosed that includes a dipole antenna and a slot antenna extending along a first axis. The dipole antenna and the slot antenna each have a radiation pattern that is omni-directional in an azimuth plane of the Earth. The dipole antenna radiates vertically polarized electric field, and the slot antenna radiates a horizontally polarized electric field. | 11-06-2014 |
20140361941 | MULTI-TYPE ANTENNA - Exemplary embodiments are related to multi-type antennas. A device may include an antenna and a ground plane. The device may further include a low-pass filter for coupling the antenna to the ground plane in a first mode of operation and isolating the antenna from the ground plane in a second, different mode of operation. | 12-11-2014 |
20150091759 | COLLOCATED OMNIDIRECTIONAL DUAL-POLARIZED ANTENNA - An antenna structure is disclosed that includes a first antenna extending from a substrate, a second antenna formed on the substrate, and first and second parasitic elements formed on the substrate. The first antenna provides an omni-directional radiation pattern in the azimuth plane for vertically polarized signals, and the second antenna provides an omni-directional radiation pattern in the azimuth plane for horizontally polarized signals. The parasitic elements absorb and re-radiate electromagnetic waves radiated from the second antenna. | 04-02-2015 |
20150249293 | ULTRA LOW PROFILE CONFORMAL ANTENNA SYSTEM - A low profile conformal high gain multi-beam aircraft antenna includes antenna elements supported by a ground plane to create the low profile conformal high gain multi-beam aircraft antenna. Some of the antenna elements include a feeding waveguide flared in at least one of an h-plane and a v-plane. The antenna elements cooperate to create a gain pattern near a plane of the antenna. | 09-03-2015 |
20150364820 | MULTIBAND ANTENNA APPARATUS AND METHODS - The present disclosure includes multiband antenna apparatus and methods. In one embodiment, an antenna includes a loop antenna having a first corner between a first side and a second side and a second corner between the second side and a third side, a loop fed inverted F antenna comprising the loop antenna and a first arm extending from the second corner of the loop antenna, the first arm configured in parallel with the first and second sides of the loop antenna and forming a corner proximate to the first corner of the loop antenna, and a monopole antenna coupled to the first side of the loop antenna. | 12-17-2015 |
Patent application number | Description | Published |
20130164260 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 06-27-2013 |
20130177530 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 07-11-2013 |
20140017198 | INHIBITORS OF HEPATITIS C VIRUS - Compounds of Formula I are disclosed | 01-16-2014 |
20140112885 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 04-24-2014 |
20140309432 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 10-16-2014 |
20150141326 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 05-21-2015 |
20150175655 | INHIBITORS OF HEPATITIS C VIRUS - Compounds of Formula I are disclosed, As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed. | 06-25-2015 |
20150299213 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 10-22-2015 |
20160083394 | ANTIVIRAL COMPOUNDS - The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 03-24-2016 |
Patent application number | Description | Published |
20090035478 | MEDIA FOR INKJET WEB PRESS PRINTING - A print media for inkjet web-press printing includes a paper base and a porous surface treatment. The porous surface treatment layer includes an inorganic pigment; at least one water-soluble and/or water-dispersible polymeric carrier; and at least one fixer. The fixer is a metal salt. A method of making print media is also disclosed. | 02-05-2009 |
20100215874 | OPTICAL RECORDING MEDIUM WITH INK RECEPTIVE COATING - The instant disclosure relates to an ink jet printable optical recording medium including a substrate having opposing surfaces, namely a recording surface and a printing surface. The printing surface of the substrate is coated with an adhesion promotion layer which includes polyurethane, a high surface area inorganic pigment having a surface area of at least 100 m | 08-26-2010 |
20110012970 | COMPOSITION, METHOD AND SYSTEM FOR MAKING HIGH WHITENESS INKJET MEDIA - The present application relates to a surface treatment composition for inkjet media, including: starch; fluorescence whitening agent selected from the group consisting of nonionic, cationic, and anionic fluorescence whitening agents, and combinations thereof; metallic salt including cation and anion, the cations being selected from monovalent metal ions, multiple valent metal ions, and combinations and derivatives thereof, and the anions being selected from the group consisting of fluoride, chloride, iodide, bromide, nitrate, phosphate, chlorate, acetate, and combinations and derivatives thereof; and chemical chelant. The application also relates to a method of making surface-treated inkjet media, including providing a base stock including cellulose paper and applying a surface treatment composition to the base stock. The application also relates to a paper coated with the surface treatment composition and a system of inkjet printing with surface treated inkjet media. | 01-20-2011 |
20110091666 | MEDIA FOR USE IN INKJET PRINTING - An inkjet printable article includes an ink receptive layer bonded to a paper substrate. The ink receiving layer includes particles, polymeric binder and colorant durability enhancer. From about 60% to about 95% by total dry weight of the ink receiving layer is particles selected from the group consisting of clay, kaolin, and combinations thereof. The polymeric binder is selected from the group consisting of polyvinyl alcohol, styrene butadiene, acrylonithle-butadiene latex, and combinations thereof. The colorant durability enhancer is selected from the group consisting of boric acid, borax, phenyl boronic acid, butyl boronic acid, sodium tetraborate, and combinations thereof. | 04-21-2011 |
20110104406 | MEDIA FOR INKJET PRINTING - An ink-jet recording medium is disclosed which comprises a paper substrate having a surface for receiving an ink-jet ink containing a pigmented colorant. The surface is treated with at least one co-crystalline salt, which become associated with the substrate surface. The co-crystalline salt is capable of crashing pigmented colorants on the paper surface, and its use may help protect paper manufacturing equipment from corrosion. | 05-05-2011 |
20110205287 | COMPOSITION AND PRINT MEDIUM - One or more surface treatment compositions and print mediums are disclosed. The surface treatment compositions may comprise at least one surface sizing agent and at least one monovalent and at least one, multivalent metallic salt. Also disclosed are methods for the production of the surface treatment composition and print media with the composition. | 08-25-2011 |
20110244147 | Liquid Toner Digitally Printable Media - A liquid toner digitally printable media including: a paper substrate; and a toner receiving layer established on at least one surface of the paper substrate. The toner receiving layer includes: pigments, binders, and at least one of cationic polymers and metallic salts. The pigments are from 60 to 95% of total dry weight of the toner receiving layer. The pigments include a major pigment which is at least 60 weight percent of total pigment dry weight. The major pigment includes a rod-like pigment selected from the group consisting of ground calcium carbonate, precipitated calcium carbonate, other rod-like forms of calcium pigment, and combinations thereof. | 10-06-2011 |
Patent application number | Description | Published |
20080200491 | 1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel - The present invention relates to certain 1,2-dihydro-spiro[3H-indole-3,4′-piperidine]compounds of Formula (Ia): and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein G, R1, R2, R3, R4, R5, and Ar are as disclosed herein (“Compound(s) of the Invention”), which are useful, for example, as cardio-protective and/or neuro-protective agents. The invention also provides pharmaceutical compositions comprising a Compound of the Invention and methods for treating, preventing and/or managing a vascular, cardiovascular or neurological disease or disorder, comprising administering to a patient in need thereof a Compound of the Invention. | 08-21-2008 |
20090036448 | PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF - The present invention encompasses novel substituted pyrimidine compounds of Formula (I): | 02-05-2009 |
20090186895 | ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, blood clot formation, asthma or symptoms thereof, agitation or a symptom thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like. The present invention also relates to the methods for the treatment of 5-HT2A serotonin receptor associated disorders in combination with other pharmaceutical agents administered separately or together. | 07-23-2009 |
20090197935 | PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 08-06-2009 |
20110053958 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH); idiopathic PAH; familial PAH; PAH associated with a collagen vascular disease, a congenital heart disease, portal hypertension, HIV infection, ingestion of a drug or toxin, hereditary hemorrhagic telangiectasia, splenectomy, pulmonary veno-occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH); PAH with significant venous or capillary involvement; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 03-03-2011 |
20110224262 | PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 09-15-2011 |
20110245251 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Cyclohexane derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 10-06-2011 |
20120295938 | ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, blood clot formation, asthma or symptoms thereof, agitation or a symptom thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like. The present invention also relates to the methods for the treatment of 5-HT2A serotonin receptor associated disorders in combination with other pharmaceutical agents administered separately or together. | 11-22-2012 |
20130217706 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH); idiopathic PAH; familial PAH; PAH associated with a collagen vascular disease; and other diseases. | 08-22-2013 |
20140163032 | ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT 2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 06-12-2014 |
20140171469 | PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 06-19-2014 |
20140235622 | PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 08-21-2014 |
20140309192 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: | 10-16-2014 |
20150126527 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: Pulmonary arterial hypertension (PAH); idiopathic PAH; familial PAH; PAH associated with a collagen vascular disease, a congenital heart disease, portal hypertension, HIV infection, ingestion of a drug or toxin, hereditary hemorrhagic telangiectasia, splenectomy, pulmonary veno-occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH); PAH with significant venous or capillary involvement; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack, angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 05-07-2015 |
20150174102 | ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT 2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 06-25-2015 |
20150191454 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Cyclohexane derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 07-09-2015 |
20150191455 | PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD). | 07-09-2015 |
20150265576 | PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 09-24-2015 |
20150353488 | BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS - The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the histamine H3 receptor (Ia). Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders. | 12-10-2015 |